Candida albicans PLD1 activity is required for full virulence

References

• Pittet D, Wenzel RP. Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med 1995; 155: 1177–1184.
   Google Scholar
• Pfaller MA. Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. Clin Infect Dis 1996; 22\(Suppl. 2): S89—S94.
   Google Scholar
• Wingard JR. The use of fluconazole prophylaxis in patients with chemotherapy-induced neutropenia. Leuk Lymphoma 1992; 8: 353–359.
   PubMed Web of Science ®Google Scholar
• Foxman B, Marsh JV, Gillespie B, Sobel JD. Frequency and response to vaginal symptoms among white and African Amer-ican women: results of a random digit dialing survey. J Womens Health 1998; 7: 1167–1174.
   PubMed Web of Science ®Google Scholar
• Lo HJ, Kohler JR, DiDomenico B, Loebenberg D, Cacciapuoti A, Fink GR. Nonfilamentous C albicans mutants are avirulent. Cell 1997; 90: 939–949.
   PubMed Web of Science ®Google Scholar
• Rodrigues AG, Mardh PA, Pina-Vaz C, Martinez-de-Oliveira J, Fonseca AF. Germ tube formation changes surface hydrophobi-city of Candida cells. Infect Dis Obstet Gynecol 1999; 7: 222–226.
   PubMedGoogle Scholar
• Ibrahim AS, Mirbod F, Filler SG, et al. Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun 1995; 63: 1993–1998.
   PubMed Web of Science ®Google Scholar
• Hube B. Candida albicans secreted aspartyl proteinases. Curr Top Med Mycol 1996; 7: 55–69.
   PubMedGoogle Scholar
• Leberer E, Ziegelbauer K, Schmidt A, et al. Virulence and hyphal formation of Candida albicans require the Ste20p-like protein kinase CaCla4p. Curr Biol 1997; 7: 539–546.
   PubMed Web of Science ®Google Scholar
• McLain N, Dolan JW. Phospholipase D activity is required for dimorphic transition in Candida albicans. Microbiology 1997; 143: 3521–3526.
   PubMedGoogle Scholar
• Hube B, Hess D, Baker CA, Schaller M, Schafer W, Dolan JW. The role and relevance of phospholipase D1 during growth and dimorphism of Candida albicans. Microbiology 2001; 147: 861–867.
   PubMedGoogle Scholar
• Gillum AM, Tsay EY, Kirsch DR. Isolation of the Candida albicans gene for orotidine-5'-phosphate decarboxylase by com-plementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet 1984; 198: 179–182.
   Google Scholar
• Vazquez-Torres A, Jones-Carson J, Wagner RD, Warner T, Balish E. Early resistance of interleukin-10 knockout mice to acute systemic candidiasis. Infect Immun 1999; 67: 670–674.
   PubMed Web of Science ®Google Scholar
• Fonzi WA, Irwin MY. Isogenic strain construction and gene mapping in Candida albicans. Genetics 1993; 134: 717–728.
   PubMed Web of Science ®Google Scholar
• Liu H, Kohler J, Fink GR. Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog. Science 1994; 266: 1723–1726.
   Google Scholar
• Stoldt VR, Sonneborn A, Leuker CE, Ernst JF. Efglp, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi. EMBO J 1997; 16: 1982–1991.
   PubMed Web of Science ®Google Scholar
• Sherman F. Getting started with yeast. Methods Enzymol 1991; 194: 3–21.
   PubMed Web of Science ®Google Scholar
• Wang B, Biron C, She J, et al. A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3E gene. Proc Natl Acad Sci USA 1994; 91: 9402–9406.
   PubMedGoogle Scholar
• Cantorna MT, Balish E. Mucosal and systemic candidiasis in congenitally immunodeficient mice. Infect Immun 1990; 58: 1093–1100.
   PubMedGoogle Scholar
• Shaw J, Grund V, Durling L, Crane D, Caldwell HD. Dendritic cells pulsed with a recombinant chlamydial major outer mem-brane protein antigen elicit a CD4(+) type 2 rather than type 1 immune response that is not protective. Infect Immun 2002; 70: 1097–1105.
   Google Scholar
• Schaller M, Schafer W, Korting HC, Hube B. Differential expression of secreted aspartyl proteinases in a model of human oral candidosis and in patient samples from the oral cavity. Mol Microbiol 1998; 29: 605–615.
   Google Scholar
• Zupi G, Marangolo M, Arancia G, Greco C, Laudonio N, Iosi F, et al . Modulation of the cytotoxic effect of 5-fluorouracil by Nmethylformamide on a human colon carcinoma cell line. Cancer Res 1988; 48: 6193–6200.
   Google Scholar
• Lieber M, Smith B, Szakal A, Nelson-Rees W, Todaro G. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer 1976; 17: 62–70.
   Google Scholar
• Schaller M, Hube B, Ollert MW, et al . In vivo expression and localization of Candida albicans secreted aspartyl proteinases during oral candidiasis in HIV-infected patients. J Invest Dermatol 1999; 112: 383–386.
   Google Scholar
• Schaller M, Schackert C, Korting HC, Januschke E, Hube B. Invasion of Candida albicans correlates with expression of secreted aspartic proteinases during experimental infection of human epidermis. J Invest Dermatol 2000; 114: 712–717.
   Google Scholar
• Ernst JF. Transcription factors in Candida albicans -environmental control of morphogenesis. Microbiology 2000; 146: 1763–1774.
   Google Scholar